Back to microbes
11 November, 2002 by Melissa TrudingerWith all the excitement over the human genome and its potential for increasing understanding of human disease, microbial disease research has slipped out of the limelight.
One cell is enough for forensic DNA fingerprinting
31 October, 2002 by Melissa TrudingerA new technique for fingerprinting DNA from a single cell may have tremendous potential for forensic investigations and other applications, allowing individuals to be identified from just one cell.
Senate committee divided on stem cells
25 October, 2002 by Pete YoungThe outcome of a Senate committee inquiry into proposed embryonic human stem cell research legislation suggests it may require extensive surgery to pass a Senate vote.
Stem cells workshop set down for UNSW
10 October, 2002 by Melissa TrudingerThe University of NSW is holding a workshop on stem cells on November 19th for all NSW researchers working with or interested in working with stem cells.
Speaking the language of bacteria
02 October, 2002 by Graeme O'NeillMicrobial geneticist Prof Bonnie Bassler of Princeton University is a sort of bacterial linguist -- she studies how bacteria, the simplest living organisms, communicate.
Humans vs microbes: the ASM goes to war
01 October, 2002 by Graeme O'NeillMicrobiology is in ferment, says Dr Jan Tennent, and the next decade is likely to see major gains in the perennial war between humans and their microbial nemeses -- viruses, bacteria and parasites.
ES Cell refocuses cell line marketing strategy
27 September, 2002 by Pete YoungSingapore-based company ES Cell International is changing the marketing strategies for its human embryonic stem cell lines because of researchers' reluctance to part with intellectual property.
Stem cell Bill moves to the Senate
26 September, 2002 by Pete YoungThe stage has been for a final Senate debate on a Bill permitting research on embryonic human stem cells following the legislation's passage by a three-to-one margin in the House of Representatives.
Parliamentary debate continues on stem cells
26 September, 2002 by Graeme O'NeillBehind the headlines, hype and huff-and-puff politics surrounding the therapeutic use of stem cells, there is fierce debate even among the experts over which research route holds the greater promise: adult, or embryonic?
Funds lagging for new stem cell centre
25 September, 2002 by Pete YoungA skeleton administrative staff is at work on the $43.5 million National Stem Cell Centre even though Federal government has yet to sign a deed of agreement for the controversial research institute.
Politics, not science, is key to stem cell issues: Reeve
20 September, 2002 by Melissa TrudingerThe hope of millions of patients was riding on politics far more than science, paralysed actor and stem cell research advocate Christopher Reeve told delegates in a taped keynote speech at the Stem Cells 2002 conference this week.
Stem cell debate: now IVF is under threat
17 September, 2002 by Melissa TrudingerThe Federal House of Representatives agreed in principle on Monday night to pass the Research Involving Embryos Bill, voting 103 in favour to 36 against. But debate continued on the controversial bill as the first of a series of amendments was proposed.
New doubts cast on adult stem cell potential
06 September, 2002 by Melissa TrudingerResearchers at Stanford University Medical Center in the US have reported that they failed in attempts to coax adult blood-forming stem cells in mice into forming tissues other than blood and immune cells.
From footy to neuroscience: CogState branches out
05 September, 2002 by Melissa TrudingerA Melbourne company, whose test to measure cognitive abilities counts AFL teams among its customers, is branching out into biotech to develop neuroscience therapeutics.
Singapore govt awards grant to Agenix subsidiary
30 August, 2002 by Pete YoungA Singapore government decision to award a major grant to a subsidiary of Australian listed biotech Agenix is being labelled a "great vote of confidence" by Agenix CEO Don Home.
